Ignite Creation Date:
2025-12-25 @ 12:10 AM
Ignite Modification Date:
2025-12-25 @ 10:10 PM
Study NCT ID:
NCT03434158
Status:
COMPLETED
Last Update Posted:
2022-11-03
First Post:
2018-01-26
Is NOT Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
Olaparib Maintenance in Patients With MCRPC After Docetaxel Treatment Reaching Partial or Stable Response (IMANOL)
Sponsor:
Spanish Oncology Genito-Urinary Group
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2018-02-06
Start Date Type:
ACTUAL
Primary Completion Date:
2022-05-12
Primary Completion Date Type:
ACTUAL
Completion Date:
2022-05-12
Completion Date Type:
ACTUAL
First Submit Date:
2018-01-26
First Submit QC Date:
None
Study First Post Date:
2018-02-15
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2022-11-02
Last Update Post Date:
2022-11-03
Last Update Post Date Type:
ACTUAL